SVRA - Savara Inc

https://www.savarapharma.com

Hold Momentum: Bearish

Recent News

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2025 in Savara Inc. Lawsuit - SVRA - Savara ( NASDAQ:SVRA )

Benzinga • 0 minutes ago • score: -0.05

NEW YORK, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. SVRA. Shareholders who purchased shares of SVRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Bullish

SVRA Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Savara Inc. Securities Class Action Lawsuit - Savara ( NASDAQ:SVRA )

Benzinga • 2 days, 19 hours ago • score: 0.16

SAN DIEGO, Sept. 12, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Savara Inc. SVRA securities between March 7, 2024 and May 23, 2025.

Neutral

Portnoy Law Firm Announces Class Action on Behalf of Savara, Inc. Investors - Savara ( NASDAQ:SVRA )

Benzinga • 3 days, 20 hours ago • score: 0.05

LOS ANGELES, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Savara, Inc., ( "Savara" or the "Company" ) SVRA investors of a class action on behalf of investors that bought securities between March 7, 2024 and May 23, 2025, inclusive ( the "Class Period" ) .

Neutral

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. ( NASDAQ: APLT ) ; Lantheus Holdings, Inc. ( NASDAQ: LNTH ) ; Savara Inc. ( NASDAQ: SVRA ) ; and Unicycive Therapeutics, Inc. ( NASDAQ: UNCY ) : Grabar Law Office is Investigating Claims on Your Behalf - Lantheus Holdings ( NASDAQ:LNTH ) , Applied Therapeutics ( NASDAQ:APLT )

Benzinga • 4 days, 3 hours ago • score: 0.12

PHILADELPHIA, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Applied Therapeutics APLT - Class Action Reaches Settlement: A securities fraud class action against Applied Therapeutics, Inc. APLT and certain of its officers has reached a settlement.

Bullish

SVRA Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Savara Inc. - Savara ( NASDAQ:SVRA )

Benzinga • 5 days, 16 hours ago • score: 0.16

SAN DIEGO, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Savara Inc. SVRA securities between March 7, 2024 and May 23, 2025.

Neutral

SAVARA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Savara Inc. and Encourages Investors to Contact the Firm - Savara ( NASDAQ:SVRA )

Benzinga • 5 days, 18 hours ago • score: 0.07

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Savara ( SVRA ) To Contact Him Directly To Discuss Their Options

Neutral

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Savara Inc. ( SVRA ) - Savara ( NASDAQ:SVRA )

Benzinga • 5 days, 23 hours ago • score: 0.06

NEW YORK, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons or entities who purchased or otherwise acquired Savara ...

Neutral

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA - Savara ( NASDAQ:SVRA )

Benzinga • 2 months, 3 weeks ago • score: -0.04

NEW YORK, June 23, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. ( "Savara" or the "Company" ) SVRA. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas.

52W High

$4.70

52W Low

$1.89

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.56

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-4.76

EV/Revenue (<3 favorable)

11.91

P/S (TTM) (<3 favorable)

131150.00

P/B (<3 favorable)

5.34

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

5.38%

Institutions (25–75% balanced)

100.03%

Shares Outstanding

172,837,000

Float

86,678,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

1,000

Gross Profit (TTM)

-77,417,000

EPS (TTM)

-0.51

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.99%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.2932

0.3191

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025